BioSpace News Archive

Drug Development

Antengene Publishes Preclinical Paper on PD-L1/4-1BB Bispecific Antibody ATG-101 in Renowned Oncology Journal Cancer Research

Antengene Corporation Limited (“Antengene” SEHK: 6996.HK) today announced that results of its preclinical studies on ATG-101 (PD-L1/4-1BB bispecific antibody) were published in Cancer Research in a paper titled ATG-101 is a tetravalent PD-L1×4-1BB bispecific antibody that stimulates anti-tumor immunity through PD-L1 blockade and PD-L1-directed 4-1BB activation[1].

March 19, 2024
·
5 min read
Pharm Country

Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock

Aquestive Therapeutics, Inc. announced the pricing of an underwritten public offering of 16,666,667 shares of its common stock at a public offering price of $4.50 per share.

March 19, 2024
·
5 min read
BioMidwest

New Alzheimer’s Association Report Reveals Top Stressors for Caregivers and Lack of Care Navigation Support and Resources

The Alzheimer’s Association 2024 Alzheimer’s Disease Facts and Figures report reveals that both dementia caregivers and health care workers report difficulties in navigating dementia care within the U.S. health care system.

March 19, 2024
·
6 min read